NorInnova Invest acquires Calanus
Norinnova Invest has invested in Calanus AS and now owns 15,8 percent of the company.
Calanus, established in 2002, is developing new health and nutrition supplements, as well as specialty pharmaceutical preparations, based on the harvestable marine crustacean copepod (Calanus finmarchicus). The company also participates in the development of sustainable harvesting of the raw material.
Read more
| Fund | NorInnova Invest |
| Portfolio Company | Calanus |
| Date of Transaction | 2009-12-10 |
| Transaction | Acquisition |
| Seller | |
| Buyer | |
| Size of Transaction | |
| Ind. Focus | Life Science |
| Geography | Norway |
| Stage | Seed |